(Q37632263)

21 August 2017

1 reference

title

The role of AMP-activated protein kinase in the cardiovascular system (English)

1 reference

21 August 2017

1 reference

Daisuke Nagata

1

1 reference

21 August 2017

Yasunobu Hirata

series ordinal

2

1 reference

21 August 2017

publication date

13 November 2009

1 reference

21 August 2017

published in

Hypertension Research

1 reference

21 August 2017

volume

33

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

22-28

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2009.187

21 August 2017

exact match

0 references

cites work

AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

New roles for the LKB1-->AMPK pathway.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

A revised model for AMP-activated protein kinase structure: The alpha-subunit binds to both the beta- and gamma-subunits although there is no direct binding between the beta- and gamma-subunits

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

LKB1 is the upstream kinase in the AMP-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

TSC2 mediates cellular energy response to control cell growth and survival

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Energy-dependent regulation of cell structure by AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Development by self-digestion: molecular mechanisms and biological functions of autophagy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Upregulation of 5'-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Identification of a gene responsible for familial Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

AMP-activated protein kinase in the heart: role during health and disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

A new constitutively active mutant of AMP-activated protein kinase inhibits anoxia-induced apoptosis of vascular endothelial cell.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.187

7 January 2021

Identifiers

DOI

10.1038/HR.2009.187

1 reference

21 August 2017

1 reference